Hepcinat LP Tablet
Hepcinat-Lp Tablet helps in the treatment of chronic hepatitis C (HCV). This drug is used in a combination with another drug, to prevent the spread of HCV throughout the body.
Patients who have liver issues, or kidney problems and are undergoing dialysis, are not advised the use of Hepcinat-Lp Tablet. Also inform your doctor about any other health issues you are suffering from and if you are taking any medicines to treat them.
Hepcinat-Lp Tablet is meant to be taken orally, either with food or without. Antacids containing magnesium or aluminum should not be consumed for a few hours after taking the drug. The drug should be taken regularly, preferably at a particular time each day. Try not to miss any doses.
Drug = Ledipasvir + Sofosbuvir
Strength = 90 Mg + 400 Mg
Manufacturer = NatcoPharma Ltd.
Take Hepcinat-Lp Tablet in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Hepcinat-Lp Tablet is to be taken with food.
Hepcinat 400 Mg
Hepcinat LP Tablet
Ulcers or white spots in the mouth
Lower back pain
Muscle pain and cramps
Alcohol:-Interaction with alcohol is unknown. Please consult your doctor.
Pregnancy:-Hepcinat-LP Tablet is probably safe to use during pregnancy.
Animal studies have shown low or no adverse effect on the foetus, however, there are limited human studies. Please consult your doctor.
Lactation:-Hepcinat-LP Tablet is probably safe to use during lactation. Limited human data suggests that the drug does not represent a significant risk to the baby.
Driving:-Do not drive unless you are feeling well.
Hepcinat-LP Tablet, when taken together with other medicines for the treatment of hepatitis c infection, may produce dizziness, blurred vision and this may affect your ability to drive.
Kidney:-Hepcinat-LP Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Hepcinat-LP Tablet may be needed. Please consult your doctor.
Limited information is available on use of Hepcinat-LP Tablet in these patients. No dose adjustment is recommended in patients with mild to moderate kidney disease.
Liver:-Hepcinat-LP Tablet is safe to use in patients with liver disease. No dose adjustment of Hepcinat-LP Tablet is recommended.
Hepcinat LP Tablet is used in the treatment of chronic hepatitis C virus infection for preventing the growth and spread of the virus in the body.
Hepcinat-Lp Tablet is used in patients with hepatocellular carcinoma and hepatitis C, who are planning to undergo liver transplantation in order to prevent the recurrence of the infection.